¿Son las válvulas autoexpandibles una opción válida en las bicúspides?

Are Self-Expandable Valves a Valid Option in Bicuspids?

Bicuspid Aortic Valves (VAV) are challenging for TAVR given its anatomical characteristics and the important presence of calcification. However, current data are promising.  Even though traditionally excluded from the larger randomized studies, self-expandable valves appear to have similar evolution to tricuspid aortic valves (TAV) with severe stenosis.  Researchers looked at the Low-Risk Bicuspid Study and<a href="https://solaci.org/en/2022/03/16/are-self-expandable-valves-a-valid-option-in-bicuspids/" title="Read more" >...</a>

The Most Read Articles in Interventional Cardiology

01- Ticagrelor or Prasugrel in ST Elevation MI In patients undergoing ST elevation acute myocardial infarction (STEMI) receiving primary PCI, no significative differences between prasugrel and ticagrelor were found. However, the latter was associated to a significantly higher number of repeat MI when considered separately.  Read more HERE 02- Number of Hours of Sleep and<a href="https://solaci.org/en/2020/12/02/the-most-read-articles-in-interventional-cardiology/" title="Read more" >...</a>

TAVI: Balón expandible o autoexpandible ¿Cuál es la respuesta?

Considerations for Optimal Device Selection in TAVR

Many studies have tried to answer the question about whether there is a superior device in transcatheter aortic valve replacement (TAVR). Today, there is no evidence to support such claim, and most patients will likely find operator experience more beneficial than any device per se.   However, there are certain patients with specific characteristics that might<a href="https://solaci.org/en/2020/09/24/considerations-for-optimal-device-selection-in-tavr/" title="Read more" >...</a>

Valve-in-Valve: Good Evolution at Long-Term

Courtesy of Dr. Carlos Fava. In the last decades, there has been a marked increase in the use bioprosthetic valves in aortic position given their benefits over mechanical valves. However, long term follow-up has shown structural valve degeneration (SVD). Given the risk of a second surgery after TAVR, valve-in-valve (ViV) has been on the rise,<a href="https://solaci.org/en/2020/08/19/valve-in-valve-good-evolution-at-long-term/" title="Read more" >...</a>

balon_farmacologico_reestenosis_instrastent

Two-Stent Strategy is Safer in True Bifurcation Lesions

Courtesy of Dr. Carlos Fava.  DES have improved PCI outcomes, but one of its biggest challenges continues to be bifurcations (especially when we have to use two stents, since it’s been associated to higher restenosis and stent thrombosis rates).  Left main coronary artery true bifurcation lesions are the ones that generate the greatest challenge and<a href="https://solaci.org/en/2020/07/28/two-stent-strategy-is-safer-in-true-bifurcation-lesions/" title="Read more" >...</a>

SOLACI Peripheral | Clinical Case Discussion

SOLACI’s Department of Peripheral Endovascular Interventions is promoting the analysis of challenging clinical cases on peripheral interventions so as to foster the participation and engagement of all SOLACI members. In this first issue, we present a clinical case around carotid artery stenting. Read thoroughly the case below and take part in an unrestricted discussion through<a href="https://solaci.org/en/2020/06/17/solaci-peripheral-clinical-case-discussion/" title="Read more" >...</a>

SOLACI-CACI 2021 Preliminary Agenda

Check out the main topics of the upcoming SOLACI-CACI 2021 Congress. Save the Date!   Special Session About the COVID-19 Pandemic   Managing Cardiovascular disease and Cath Lab during the COVID-19 Pandemic Live Case Transmissions Coronary and Structural cases performed by distinguished international and national operators. Coronary Track   Myocardial Infarction, Left Main session, Complex<a href="https://solaci.org/en/2020/06/09/solaci-caci-2021-preliminary-agenda/" title="Read more" >...</a>

The most read scientific articles in april

The most read scientific articles on interventional cardiology in april

01- ECS Guidelines for COVID-19 Management One of the first statements in this document points out these are not “regular guidelines” developed after thorough analysis of all the available evidence published since the last update. Instead, they are meant to provide temporary basic management pointers on how to handle different scenarios of cardiac patients in the<a href="https://solaci.org/en/2020/05/06/the-most-read-scientific-articles-on-interventional-cardiology-in-april/" title="Read more" >...</a>

SURTAVI Follow-Up Completed with Good News

The assessment of all severe aortic stenosis patients at intermediate risk of the SURTAVI was finally completed, confirming inferiority against the traditional surgical replacement (SAVR) in hard points such as all-cause mortality and disabling stroke.  The aim of this study was to report SURTAVI 2-year outcomes (Surgical Replacement and Transcatheter Aortic Valve Implantation) and confirm<a href="https://solaci.org/en/2020/04/29/surtavi-follow-up-completed-with-good-news/" title="Read more" >...</a>

Ecuador Regional Sessions 2020: See the Presentations

The 40th Regional Sessions held in Ecuador in 2020 was a successful scientific event that counted with the participation of reputed Latin American interventionists. We want to express our gratitude to all participants, attendees and representatives of the industry who contributed to the highest quality of this event.  Next, we share some of the presentations<a href="https://solaci.org/en/2020/04/13/ecuador-regional-sessions-2020-see-the-presentations/" title="Read more" >...</a>